Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P26010
UPID:
ITB7_HUMAN
Alternative names:
Gut homing receptor beta subunit
Alternative UPACC:
P26010; Q9UCP7; Q9UCS7
Background:
Integrin beta-7, also known as the gut homing receptor beta subunit, plays a crucial role in lymphocyte migration and homing to gut-associated lymphoid tissue (GALT). It mediates adhesion by interacting with cell surface molecules like MADCAM1, VCAM1, and fibronectin. These interactions are essential for the immune system's surveillance and response within the gastrointestinal tract.
Therapeutic significance:
Understanding the role of Integrin beta-7 could open doors to potential therapeutic strategies. Its involvement in lymphocyte migration makes it a key target for modulating immune responses, particularly in gastrointestinal diseases and conditions related to immune system dysfunction.